Don Jung
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Transplantation top 10%
- Renal Transplantation Outcomes and Treatments
Papers in
-
- Cancer, Hypoxia, and Metabolism 4
- Cancer Genomics and Diagnostics 1
-
- Aldose Reductase and Taurine 2
- Co-authors
- Charles P. Hart (3 shared papers)Mark Matteucci (3 shared papers)Jacob A. Kaizerman (1 shared paper)Jinwei Wang (1 shared paper)Zhijian Yang (1 shared paper)Timothy F. Stanton (1 shared paper)James Evans (2 shared papers)Robert M. Hoffman (1 shared paper)
- Journals
- Cancer Research (2 papers)Journal of Clinical Oncology (1 paper)Journal of Medicinal Chemistry (1 paper)The American Journal of Gastroenterology (1 paper)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (1 paper)
- Partner nations
- United StatesGermanyChina
In The Last Decade
Don Jung
8 papers receiving 238 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 140
- Transplantation 19
- Biotechnology 30
- Oncology 54
- Molecular Biology 101
Countries citing papers authored by Don Jung
This map shows the geographic impact of Don Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Don Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Don Jung more than expected).
Fields of papers citing papers by Don Jung
This network shows the impact of papers produced by Don Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Don Jung. The network helps show where Don Jung may publish in the future.
Co-authors
The 25 scholars most cited alongside Don Jung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 188 | |
| 2 | 1997 | 32 | |
| 3 | 2016 | 21 | |
| 4 | Phase I trial of glycolitic inhibition with 2-deoxyglucose and docetaxel for patients with solid tumors | 2006 | 4 |
| 5 | 2007 | 4 | |
| 6 | 2018 | 3 | |
| 7 | 2016 | 1 | |
| 8 | 2024 | 1 | |
| 9 | 2010 | 1 |
About Don Jung
Don Jung is a scholar working on Cancer Research, Cell Biology, Oncology, Biotechnology and Surgery, having authored 9 papers that have together received 255 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), Cancer-related Molecular Pathways (2 papers), Cancer Research and Treatments (2 papers), Aldose Reductase and Taurine (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), Chemotherapy-induced organ toxicity mitigation (1 paper), Epigenetics and DNA Methylation (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Cancer Research (140 citations), Transplantation (19 citations), Biotechnology (30 citations), Oncology (54 citations) and Molecular Biology (101 citations). Don Jung has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Charles P. Hart, Mark Matteucci, Jacob A. Kaizerman, Jinwei Wang, Zhijian Yang, Timothy F. Stanton, James Evans, Robert M. Hoffman, Monica Banica and Lingyun Lan. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Journal of Medicinal Chemistry, The American Journal of Gastroenterology and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.